α-Amino bisphosphonate triazoles serve as GGDPS inhibitors
Bioorganic & Medicinal Chemistry Letters · 2024
DOI: 10.1016/j.bmcl.2024.129659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2024. Verfasst von Nathaniel R Gehrke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, US. Hauptthemen laut MEDLINE: Diphosphonates, Enzyme Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Depletion of cellular levels of geranylgeranyl diphosphate by inhibition of the enzyme geranylgeranyl diphosphate synthase (GGDPS) is a potential strategy for disruption of protein transport by limiting the geranylgeranylation of the Rab proteins that regulate intracellular trafficking. As such, there is interest in the development of GGDPS inhibitors for the treatment of malignancies characterized by abnormal protein production, including multiple myeloma. Our previous work has explored the structure-function relationship of a series of isoprenoid triazole bisphosphonate-based GGDPS inhibitors, with modifications having impact on enzymatic, cellular and in vivo activities. We have synthesized a new series of α-amino bisphosphonates to understand the impact of modifying the alpha position with a moiety that is potentially linkable to other agents. Bioassays evaluating the enzymatic and cellular activities of these compounds demonstrate that incorporation of the α-amino group affords compounds with GGDPS inhibitory activity which is modulated by isoprenoid tail chain length and olefin stereochemistry. These studies provide further insight into the complexity of the structure-function relationship and will enable future efforts focused on tumor-specific drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, US.
- Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, US.
- Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, US; Department of Chemistry, Bangladesh University of Engineering and Technology (BUET), Dhaka-1000, Bangladesh.
- Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, US; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, US.
- Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, US; Department of Pharmacology, University of Iowa, Iowa City, IA 52242-1109, US. Electronic address: david-wiemer@uiowa.edu.
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Gehrke, N. R., Feng, D., Ayub Ali, M., Maalouf, M. A., Holstein, S. A., & Wiemer, D. F. (2024). α-Amino bisphosphonate triazoles serve as GGDPS inhibitors. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2024.129659
Vancouver
Gehrke NR, Feng D, Ayub Ali M, Maalouf MA, Holstein SA, Wiemer DF. α-Amino bisphosphonate triazoles serve as GGDPS inhibitors. Bioorganic & Medicinal Chemistry Letters. 2024. doi:10.1016/j.bmcl.2024.129659
BibTeX
@article{Gehrke2024,
author = {Gehrke, Nathaniel R and Feng, Dan and Ayub Ali, Md and Maalouf, Mona A and Holstein, Sarah A and Wiemer, David F},
title = {α-Amino bisphosphonate triazoles serve as GGDPS inhibitors},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2024},
doi = {10.1016/j.bmcl.2024.129659}
}
EUVIMED